Einfach Bitcoin kaufen: Mit dem Code "FINANZEN" sparen Sie 21% der Gebühren für 6 Monate bei Coinfinity. Jetzt loslegen -w-
01.09.2014 18:30:00

Fast Growing SuperSonic Imagine Brings Top Management to the Next Phase

Regulatory News :

SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814), a company specialized in ultrasound medical imaging, today announces that Tom Egelund has been named Chief Operating Officer, effective September 1st, 2014.

Mr Egelund brings 20 years of top-level management experience and global business leadership in medical imaging and, more recently, printing technology industries. From 2004 to 2014 Mr Egelund served as Executive Vice President and divisional CEO for wide format printing systems at Océ, a publicly listed company and since 2011 part of the Canon Group. During the ten preceding years he held senior executive leadership positions at major European companies serving the healthcare sector with medical imaging and medical IT systems.

Throughout his career Mr. Egelund has managed businesses successfully both in terms of growth and earnings. He led organic growth programs as well as acquisitions and post-merger integrations. He was actively involved in all industry processes, from technology development to commercialization. Mr Egelund has a proven record of building strong and high performance management teams.

It is the intention of the Supervisory Board of SuperSonic Imagine to name Mr Egelund President and CEO on April 2015, succeeding Mr Jacques Souquet, founder of the company. Mr. Souquet, as member of the Executive team and Chief Innovation Officer of SuperSonic Imagine, will continue to be fully engaged with SuperSonic Imagine. He will concentrate on strategic matters and the company’s innovation policy, focusing on novel ultrasound product concepts and their clinical application.

Mr. Souquet, Founder and Chief Executive Officer commented: "During the last ten years I had the great opportunity to build this company, which brings such unique and successful ultrasound technology to the market. Now is the time for our next level of growth and to plan for the next phase in the leadership of the company. Tom Egelund’s appointment will enable me to focus on activities where my experience and background in the ultrasound industry can be most leveraged”.

Hans Barella, Chairman of the Supervisory Board said: "We welcome this key addition to the company’s top management. Mr Egelund brings leadership that fits very well with the company’s ambition to continuously enhance its business position as an innovation leader growing at a pace far exceeding the growth of the ultrasound market. This step will enable Mr. Souquet to focus even deeper on the company’s strategy and innovation policy so that his extensive ultrasound knowledge and great vision will be of maximum value to the company.”

Mr. Egelund, Chief Operating Officer comments: "I am very excited to join SuperSonic Imagine. The company is successful because its breakthrough ultrasound technology and products have been clearly proven in the market with endorsement by leading clinicians around the world. SuperSonic Imagine has got the talent and committed leadership that provides every opportunity to realize compelling future growth.”

Next press release: half-year financial results on September 3rd, 2014

About SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™ Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer® in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com

Nachrichten zu Supersonic Imagine SAmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Supersonic Imagine SAmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!